The xanthine oxidoreductase (XOR) enzyme catalyzes the oxidative hydroxylation of hypoxanthine to xanthine and xanthine to uric acid and it is considered a target for the treatment of hyperuricemia and gout [55]. The gene discussed is XDH; the disease is gout.